Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation

Published:2022-02 Issue: Volume:56 Page:151860
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Khanlari Mahsa,Wang Xiaoqiong,Loghavi Sanam,Wang Sa A.,Li Shaoying,Thakral Beenu,Bueso-Ramos Carlos E.,Yin C. Cameron,Kanagal-Shamanna Rashmi,Khoury Joseph D.,Patel Keyur P.,Popat Uday R.,Medeiros L. Jeffrey,Konoplev Sergej

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference29 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues,2017

2. Revised response criteria for myelofibrosis: international working group-myeloproliferative neoplasms research and treatment (IWG-MRT) and european LeukemiaNet (ELN) consensus report;Tefferi;Blood,2013

3. Myelofibrosis with myeloid metaplasia;Tefferi;N Engl J Med,2000

4. Improving survival trends in primary myelofibrosis: an international study;Cervantes;J Clin Oncol,2012

5. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international internet-based survey of 1179 MPD patients;Mesa;Cancer,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis;Laboratory Medicine;2024-04-11

2. Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives;Leukemia;2023-03-04